SaintMed Past Earnings Performance
Past criteria checks 1/6
SaintMed's earnings have been declining at an average annual rate of -7.5%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 2% per year. SaintMed's return on equity is 6.4%, and it has net margins of 6.6%.
Key information
-7.5%
Earnings growth rate
-11.5%
EPS growth rate
| Healthcare Industry Growth | 23.6% |
| Revenue growth rate | 2.0% |
| Return on equity | 6.4% |
| Net Margin | 6.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How SaintMed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 817 | 54 | 231 | 0 |
| 30 Jun 24 | 748 | 37 | 219 | 0 |
| 31 Mar 24 | 798 | 61 | 216 | 0 |
| 31 Dec 23 | 827 | 79 | 207 | 0 |
| 30 Sep 23 | 750 | 54 | 203 | 0 |
| 30 Jun 23 | 1,009 | 110 | 205 | 0 |
| 31 Mar 23 | 1,470 | 168 | 208 | 0 |
| 31 Dec 22 | 2,010 | 297 | 218 | 0 |
| 30 Sep 22 | 2,278 | 347 | 222 | 0 |
| 30 Jun 22 | 2,535 | 469 | 232 | 0 |
| 31 Mar 22 | 2,174 | 448 | 228 | 0 |
| 31 Dec 21 | 1,621 | 320 | 217 | 0 |
| 30 Sep 21 | 1,413 | 303 | 208 | 0 |
| 30 Jun 21 | 856 | 123 | 192 | 0 |
| 31 Mar 21 | 704 | 88 | 179 | 0 |
| 31 Dec 20 | 661 | 78 | 172 | 0 |
| 30 Sep 20 | 569 | 48 | 171 | 0 |
| 31 Dec 19 | 619 | 60 | 172 | 0 |
| 31 Dec 18 | 506 | 35 | 78 | 0 |
| 31 Dec 17 | 469 | 39 | 137 | 0 |
| 31 Dec 16 | 565 | 55 | 135 | 0 |
Quality Earnings: SMD-R has a high level of non-cash earnings.
Growing Profit Margin: SMD-R's current net profit margins (6.6%) are lower than last year (7.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SMD-R's earnings have declined by 7.5% per year over the past 5 years.
Accelerating Growth: SMD-R's earnings growth over the past year (1.2%) exceeds its 5-year average (-7.5% per year).
Earnings vs Industry: SMD-R earnings growth over the past year (1.2%) did not outperform the Healthcare industry 11.1%.
Return on Equity
High ROE: SMD-R's Return on Equity (6.4%) is considered low.